Key points from article :
44 US states filed a lawsuit against leading pharma for unlawful inflation of generic drug prices.
Increased prices of more than 100 generic drugs that treat various diseases.
Competitors agreed to cooperate on pricing and raised prices by as much as 1000 per cent on many drugs as possible.
Most of the collusive activity occurred from July 2013 to January 2015.